Cargando…

Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations

BACKGROUND: Hepatocellular Carcinoma is the third most common cause of cancer related death worldwide, often diagnosed by measuring serum AFP; a poor performance stand-alone biomarker. With the aim of improving on this, our study focuses on plasma proteins identified by Mass Spectrometry in order to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fye, Haddy K. S., Wright-Drakesmith, Cynthia, Kramer, Holger B., Camey, Suzi, da Costa, Andre Nogueira, Jeng, Adam, Bah, Alasana, Kirk, Gregory D., Sharif, Mohamed I. F., Ladep, Nimzing G., Okeke, Edith, Hainaut, Pierre, Taylor-Robinson, Simon D., Kessler, Benedikt M., Mendy, Maimuna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728326/
https://www.ncbi.nlm.nih.gov/pubmed/23935864
http://dx.doi.org/10.1371/journal.pone.0068381
_version_ 1782278842379927552
author Fye, Haddy K. S.
Wright-Drakesmith, Cynthia
Kramer, Holger B.
Camey, Suzi
da Costa, Andre Nogueira
Jeng, Adam
Bah, Alasana
Kirk, Gregory D.
Sharif, Mohamed I. F.
Ladep, Nimzing G.
Okeke, Edith
Hainaut, Pierre
Taylor-Robinson, Simon D.
Kessler, Benedikt M.
Mendy, Maimuna E.
author_facet Fye, Haddy K. S.
Wright-Drakesmith, Cynthia
Kramer, Holger B.
Camey, Suzi
da Costa, Andre Nogueira
Jeng, Adam
Bah, Alasana
Kirk, Gregory D.
Sharif, Mohamed I. F.
Ladep, Nimzing G.
Okeke, Edith
Hainaut, Pierre
Taylor-Robinson, Simon D.
Kessler, Benedikt M.
Mendy, Maimuna E.
author_sort Fye, Haddy K. S.
collection PubMed
description BACKGROUND: Hepatocellular Carcinoma is the third most common cause of cancer related death worldwide, often diagnosed by measuring serum AFP; a poor performance stand-alone biomarker. With the aim of improving on this, our study focuses on plasma proteins identified by Mass Spectrometry in order to investigate and validate differences seen in the respective proteomes of controls and subjects with LC and HCC. METHODS: Mass Spectrometry analysis using liquid chromatography electro spray ionization quadrupole time-of-flight was conducted on 339 subjects using a pooled expression profiling approach. ELISA assays were performed on four significantly differentially expressed proteins to validate their expression profiles in subjects from the Gambia and a pilot group from Nigeria. Results from this were collated for statistical multiplexing using logistic regression analysis. RESULTS: Twenty-six proteins were identified as differentially expressed between the three subject groups. Direct measurements of four; hemopexin, alpha-1-antitrypsin, apolipoprotein A1 and complement component 3 confirmed their change in abundance in LC and HCC versus control patients. These trends were independently replicated in the pilot validation subjects from Nigeria. The statistical multiplexing of these proteins demonstrated performance comparable to or greater than ALT in identifying liver cirrhosis or carcinogenesis. This exercise also proposed preliminary cut offs with achievable sensitivity, specificity and AUC statistics greater than reported AFP averages. CONCLUSIONS: The validated changes of expression in these proteins have the potential for development into high-performance tests usable in the diagnosis and or monitoring of HCC and LC patients. The identification of sustained expression trends strengthens the suggestion of these four proteins as worthy candidates for further investigation in the context of liver disease. The statistical combinations also provide a novel inroad of analyses able to propose definitive cut-offs and combinations for evaluation of performance.
format Online
Article
Text
id pubmed-3728326
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37283262013-08-09 Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations Fye, Haddy K. S. Wright-Drakesmith, Cynthia Kramer, Holger B. Camey, Suzi da Costa, Andre Nogueira Jeng, Adam Bah, Alasana Kirk, Gregory D. Sharif, Mohamed I. F. Ladep, Nimzing G. Okeke, Edith Hainaut, Pierre Taylor-Robinson, Simon D. Kessler, Benedikt M. Mendy, Maimuna E. PLoS One Research Article BACKGROUND: Hepatocellular Carcinoma is the third most common cause of cancer related death worldwide, often diagnosed by measuring serum AFP; a poor performance stand-alone biomarker. With the aim of improving on this, our study focuses on plasma proteins identified by Mass Spectrometry in order to investigate and validate differences seen in the respective proteomes of controls and subjects with LC and HCC. METHODS: Mass Spectrometry analysis using liquid chromatography electro spray ionization quadrupole time-of-flight was conducted on 339 subjects using a pooled expression profiling approach. ELISA assays were performed on four significantly differentially expressed proteins to validate their expression profiles in subjects from the Gambia and a pilot group from Nigeria. Results from this were collated for statistical multiplexing using logistic regression analysis. RESULTS: Twenty-six proteins were identified as differentially expressed between the three subject groups. Direct measurements of four; hemopexin, alpha-1-antitrypsin, apolipoprotein A1 and complement component 3 confirmed their change in abundance in LC and HCC versus control patients. These trends were independently replicated in the pilot validation subjects from Nigeria. The statistical multiplexing of these proteins demonstrated performance comparable to or greater than ALT in identifying liver cirrhosis or carcinogenesis. This exercise also proposed preliminary cut offs with achievable sensitivity, specificity and AUC statistics greater than reported AFP averages. CONCLUSIONS: The validated changes of expression in these proteins have the potential for development into high-performance tests usable in the diagnosis and or monitoring of HCC and LC patients. The identification of sustained expression trends strengthens the suggestion of these four proteins as worthy candidates for further investigation in the context of liver disease. The statistical combinations also provide a novel inroad of analyses able to propose definitive cut-offs and combinations for evaluation of performance. Public Library of Science 2013-07-30 /pmc/articles/PMC3728326/ /pubmed/23935864 http://dx.doi.org/10.1371/journal.pone.0068381 Text en © 2013 Fye et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fye, Haddy K. S.
Wright-Drakesmith, Cynthia
Kramer, Holger B.
Camey, Suzi
da Costa, Andre Nogueira
Jeng, Adam
Bah, Alasana
Kirk, Gregory D.
Sharif, Mohamed I. F.
Ladep, Nimzing G.
Okeke, Edith
Hainaut, Pierre
Taylor-Robinson, Simon D.
Kessler, Benedikt M.
Mendy, Maimuna E.
Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title_full Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title_fullStr Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title_full_unstemmed Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title_short Protein Profiling in Hepatocellular Carcinoma by Label-Free Quantitative Proteomics in Two West African Populations
title_sort protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west african populations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728326/
https://www.ncbi.nlm.nih.gov/pubmed/23935864
http://dx.doi.org/10.1371/journal.pone.0068381
work_keys_str_mv AT fyehaddyks proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT wrightdrakesmithcynthia proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT kramerholgerb proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT cameysuzi proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT dacostaandrenogueira proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT jengadam proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT bahalasana proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT kirkgregoryd proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT sharifmohamedif proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT ladepnimzingg proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT okekeedith proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT hainautpierre proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT taylorrobinsonsimond proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT kesslerbenediktm proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations
AT mendymaimunae proteinprofilinginhepatocellularcarcinomabylabelfreequantitativeproteomicsintwowestafricanpopulations